The trading price of Vaxart Inc (NASDAQ:VXRT) closed lower on Monday, July 07, and closing at $0.32, -25.06% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.3 and $0.43. In examining the 52-week
Vaxart Inc (NASDAQ:VXRT) price closed higher on Tuesday, July 01, and jumping 1.73% above its previous close. A look at the daily price movement shows that the last close reads $0.45, with intraday deals fluctuated between $0.436 and $0.4844. The company’s 5Y monthly beta was
Vaxart Inc (NASDAQ:VXRT) traded at $0.56 at close of the session on Monday, June 23 and made a downward move of -3.38%% on its previous day’s price. Vaxart Inc has a market cap of $127.95 million and is expected to release its quarterly earnings report
Vaxart Inc (NASDAQ:VXRT) shares, rose in value on Wednesday, June 18, with the stock price up by 3.07% to the previous day’s close as strong demand from buyers drove the stock to $0.61. Actively observing the price movement in the last trading, the stock closed
The trading price of Vaxart Inc (NASDAQ:VXRT) closed higher on Friday, June 13, and closing at $0.70, 30.73% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.4901 and $0.779. In examining the 52-week
Vaxart Inc (NASDAQ:VXRT) price closed lower on current market day and dropping -1.06% below its previous close. A look at the daily price movement shows that the last close reads $0.40. Taking into account the 52-week price action we note that the stock hit a
Vaxart Inc (NASDAQ:VXRT) concluded the trading at $0.40 on current market day with a fall of -2.10% from its closing price on previous day. Considering stock’s 52-week price range provides that VXRT hit a high price of $1.07 and saw its price falling to a
Vaxart Inc (NASDAQ:VXRT) shares, rose in value, with the stock price down by -2.36% to the previous day’s close as strong demand from buyers drove the stock to $0.45. Actively observing the price movement in the last trading, the stock closed the session at $0.46.
Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of oral recombinant vaccines, announced that its founder and chief scientific officer, Sean Tucker, will be giving a presentation at the upcoming World Vaccine Congress Washington on May 4-6, 2021.
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.